Pharma

Your Article Summary

See Latest Articles

Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
BioPure, 08/04/09

Biopure Corporation announced that it has submitted to the Food and Drug Administration an investigational new drug application to conduct a pilot phase 2 clinical trial of the company's oxygen therapeutic Hemopure. In the proposed trial Hemopure would be studied for use in the treatment of life–threatening anemia secondary to induction chemotherapy in patients with acute myeloid leukemia who refuse red blood cell transfusion.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Amgen, 12/11/09

A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin
Cancer Chemotherapy and Pharmacology, 12/11/09

Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09

 See all of Drug Trials